D.E. Shaw & Co’s ICU Medical ICUI Stock Holding History

D.E. Shaw & Co’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,100	Closed	-$278K	–	3780
2018 Q1	$278K	Hold	1,100	–	–	﹤0.01%	3188
2017 Q4	$238K	Buy	+1,100	New	+$223K	﹤0.01%	3352

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's ICUI Position: Q1 2026 in Review

D.E. Shaw & Co sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 6,605 shares — an estimated $942K sold.

D.E. Shaw & Co first reported a position in ICUI in Q2 2013 and held it in 43 quarters. The position peaked at $12.9M in Q3 2019. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

D.E. Shaw & Co reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 6,605 ICU Medical shares in Q1 2026, an estimated $942K.
D.E. Shaw & Co first reported a position in ICU Medical in Q2 2013 and held it in 43 quarters.
D.E. Shaw & Co's ICU Medical position peaked at $12.9M in Q3 2019.
275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.